COVID-19/SARS-CoV-2 related
Antiviral compounds are being studied to investigate COVID-19 and may affect the SARS-CoV-2 virus
Show/Hide Filters
5-Methoxysterigmatocystin (HB3727)
Description:Mycotoxin. Derivative of sterigmatocystin.
Purity:>98%
Undecylprodigiosin (HB4119)
Description:Anticancer agent with multiple modes of action
Purity:>93%